Case Summary. ELCA is a revascularization device that vapors thrombus and caused the "stunned platelet" phenomenon, in addition to its debulking effect on atherosclerotic plaque. Previous report demonstrated the usefulness of ELCA in acute myocardial infarction (AMI). Having experienced the case of AMI of LMT this time, we reported the usefulness of ELCA without any flow limitation of coronary artery.
Case Summary. ELCA is a revascularization device that vapors thrombus and caused the "stunned platelet" phenomenon, in addition to its debulking effect on atherosclerotic plaque. Previous report demonstrated the usefulness of ELCA in acute myocardial infarction (AMI). Having experienced the case of AMI of LMT this time, we reported the usefulness of ELCA without any flow limitation of coronary artery. Intracornary Abciximab (Bolus of 0.25 mg /Kg) was administered without any angiographicclearance of the thrombus. Hence, IV infusion of Abciximab (0.125 mcg /Kg/ mnt over 12 hours) was administered. Repeat Coronary angiogram (Video 2) showed TIMI 111 Flow with residual obstructive plaque at Mid RCA. Lesion wassuccessfully stented with 3.0 X 15 mm Stent (Endeavor Resolute, Medtronic, Minneapolis) and final angio (Video 3) showed excellent result.
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Case Summary. In some patients of STEMI, the intracoronary thrombus may be difficult to clear by any single or multiple methods of thrombus dissolution/aspiration available to us and would require unconventional strategies for successfully establishing normal coronary flow. The difference in clearance of the thrombus could be because of age of the thrombus, quantity of the thrombus, clogging /spasm of the micro circulation or multiple distal lesions/ectasia of the coronary artery.
